Skip to content

Homepage

Author: HOTH THERAPEUTICS, INC.

Posted Date:

May 28, 2026

Rocket One Accepted into AMD AI Developer Program to Advance Simulation of Next-Generation Nanomagnetic AI Accelerator Architecture for AI, Defense and Space Applications

HOTH THERAPEUTICS, INC.

May 28, 2026
Hoth Therapeutics Becomes Rocket One Inc. (Nasdaq: RKTO), Targeting the Space Economy with Next-Generation Nanomagnetic AI Chip Technology and Ultra-Low-Power, Radiation-Tolerant Computing for Space and Defense Applications

HOTH THERAPEUTICS, INC.

May 27, 2026
Hoth Therapeutics Awarded U.S. Patent for Cancer-Fighting HT-KIT Oncology Platform

HOTH THERAPEUTICS, INC.

May 26, 2026
AI Chip Energy Efficiency: Hoth Therapeutics Restructures as Rocket One Inc. to Enter the AI Semiconductor Infrastructure Market with Acquisition of Exclusive Rights to Next Generation AI Semiconductor Acceleration Technology Built on Non-Volatile Nanomagnetic Semiconductor Architecture

HOTH THERAPEUTICS, INC.

May 19, 2026
Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients

HOTH THERAPEUTICS, INC.

May 5, 2026
Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide

HOTH THERAPEUTICS, INC.

April 14, 2026
Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide

HOTH THERAPEUTICS, INC.

April 13, 2026
Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering

HOTH THERAPEUTICS, INC.

April 2, 2026
Hoth Therapeutics Announces $2.0 Million Registered Direct Offering

HOTH THERAPEUTICS, INC.

April 1, 2026
Hungary Approves Trial Expansion as HT-001 Meets Primary Endpoint in Interim Analysis with Patients Reaching ARIGA ≤1 by Week Six

HOTH THERAPEUTICS, INC.

April 1, 2026

1 2